FDA Orange Book · active-ingredient family
Gallium citrate ga-67
Gallium citrate ga-67 is approved in 4 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:GALLIUM CITRATE GA 67 · NDA 018058
4
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| GALLIUM CITRATE GA 67 | CURIUM | NDA 018058 | BS | Approved Prior to Jan 1, 1982 | |
| GALLIUM CITRATE GA 67 | GE HEALTHCARE | NDA 017700 | — | Approved Prior to Jan 1, 1982 | |
| GALLIUM CITRATE GA 67 | LANTHEUS MEDCL | NDA 017478 | — | Approved Prior to Jan 1, 1982 | |
| NEOSCAN | GE HEALTHCARE | NDA 017655 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Gallium citrate ga-67 — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
